Supply Issues & Shortages – DHSC and NHSE&I Guide

The DHSC and NHSE&I jointly published a Guide to Managing Medicines Supply and Shortages in November 2019. The guide sets […]

COVID-19 – OTC Painkiller Demand Surge

Amid news reports of panic buying of paracetamol, the Executive Director of the Healthcare Distribution Association — the membership organisation […]

COVID-19 – UK Pharmaceutical Industry Response

The Association of the British Pharmaceutical Industry have today [16/03/20] launched a ‘Responding to COVID-19‘ webpage, with information about the […]

COVID-19 + ACE-Is or ARBs – European Society of Cardiology Position Statement

There has been speculation in medical journals, online discussion forums and elsewhere about a possible link between treatment with ACE-inhibitors […]

COVID-19 – NHSEI Prescription Advice

The NHS England and Improvement Medical Director for Primary Care, Dr Nikita Kanani, has issued a COVID-19 update to General […]

Inhaler Prescribing – Carbon Footprint

The asthma inhaler patient decision aid published by NICE last year includes important information about the different carbon footprints of […]

Nexplanon – New Insertion Site

The latest edition of Drug Safety Update from the MHRA reminds Healthcare Professionals that guidance on correct insertion of Nexplanon […]

Integrated Yellow Card Reporting – 93% GP coverage

The MHRA & EMIS have announced the roll-out of integrated reporting of suspected adverse drug reactions (ADRs) to the Yellow […]

Domperidone – No Longer Authorised for use in Children <12yrs

Following a European review of new evidence showing a lack of efficacy for domperidone for nausea & vomiting in children, […]